Predicting the development of tuberculosis with the tuberculin skin test and QuantiFERON testing

Annals of the American Thoracic Society

Volumn 12, Issue 5, 2015, Pages 680-688

  Altet, Neus ^a,b   Dominguez, José ^c,d,e,f   De Souza Galvão, Maria Luiza ^a,f   Jiménez Fuentes, M Ángeles ^a   Milà, Célia ^a   Solsona, Jordi ^a   Soriano Arandés, Antonio ^a   Latorre, Irene ^c,d,e,f,i   Lara, Elisa ^a   Cantos, Adela ^a   Ferrer, María Dolores ^g   Orcau, Àngels ^g,h   Ruiz Manzano, Juan ^c,d,e   Caylà, Joan ^f,g,h  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Instituto de Investigación en Atención Primaria Jordi Gol   (Spain)

^c Institut d'Investigació Germans Trias i Pujol   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g Agencia de Salud Publica de Barcelona   (Spain)

^h Unidad de Investigacion   (Spain)

ⁱ HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

IFN ; Release assays; Tuberculosis; Tuberculosis development

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; BLOOD SMEAR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PREDICTIVE VALUE; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; CHILD; IMMUNOLOGY; INFANT; INTERFERON GAMMA RELEASE ASSAY; ISOLATION AND PURIFICATION; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; SPAIN; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SPAIN; TUBERCULIN TEST; YOUNG ADULT;

EID: 84929367648     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201408-394OC     Document Type: Article

References (29)

1. American Thoracic Society (ATS); Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
2. Leung CC, Rieder HL, Lange C, Yew WW. Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 2011;37:690-711.
3. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-1104.
4. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011;37:88-99.
5. Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Fuenzalida L, Altet N, Ausina V, Domínguez J. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. Diagn Microbiol Infect Dis 2009;65:236-246.
6. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37:100-111.
7. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, Raviglione MC; World Health Organization, International Union against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Association Working Group. European framework for tuberculosis control and elimination in countries with a low incidence: recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002;19:765-775.
8. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DP, Lalvani A. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann Intern Med 2008;149:777-787.
9. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012;142:63-75.
10. Hill PC, Jackson-Sillah D, Fox A, Brookes RH, de Jong BC, Lugos MD, Adetifa MO, Donkor SA, Aiken AM, Howie SRC, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008;3:e.1379.
11. Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010;35:1346-1353.
12. Lange C, Rieder HL. Intention to test is intention to treat. Am J Respir Crit Care Med 2011;183:3-4.
13. Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Caylà J, Domínguez J, García JM, Vidal R. SEPAR guidelines: diagnostic and treatment of tuberculosis. Arch Bronconeumol 2008;44:551-566.
14. Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis 2000;4:895-903.
15. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H. The utility of an interferon γ release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011;30:694-700.
16. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-γ release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011;15:1018-1032.
17. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, Fielding K, Wilkinson RJ, Pai M. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:45-55.
18. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-γ assay for the development of active TB disease. Am J Respir Crit Care Med 2008;177:1164-1170.
19. Haldar P, Thuraisingam H, Patel H, Pereira N, Free RC, Entwisle J, Wiselka M, Hoskyns EW, Monk P, Barer MR, et al. Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk. Thorax 2013;68:240-246.
20. Higuchi K, Harada N, Mori T, Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007;12:88-92.
21. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood IGRA for developing active TB: an update. Am J Respir Crit Care Med 2011;183:88-95.
22. Machingaidze S, Verver S, Mulenga H, Abrahams DA, Hatherill M, Hanekom W, Hussey GD, Mahomed H. Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med 2012;186:1051-1056.
23. Sollai S, Galli L, de Martino M, Chiappini E. Systematic review and meta-analysis on the utility of interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis 2014;14:S6.
24. Chang KC, Leung CC. Systematic review of interferon-γ release assays in tuberculosis: focus on likelihood ratios. Thorax 2010;65:271-276.
25. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002;40:704-706.
26. del Corral H, París SC, Marín ND, Marín DM, López L, Henao HM, Martínez T, Villa L, Barrera LF, Ortiz BL, et al. IFNγ response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 2009;4:e8257.
27. Subdirecció General de Vigilància i Resposta a Emergències de la Salut Publica, Agència de Salut Publica de Catalunya. Informe anual 2013. Situació epidemiològica i tendència de l'endèmia tuberculosa a Catalunya. Barcelona, Spain: Departament de Salut, Generalitat de Catalunya; 2015.
28. Basu Roy R, Sotgiu G, Altet-Gómez N, Tsolia M, Ruga E, Velizarova S, Kampmann B. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012;186:378-384.
29. Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010;36:925-949.